Home prices down slightly by 0.1% in Q2

The price index went down to 136.6.

Home prices in Singapore have dipped slightly in the second quarter of the year.

According to the latest statistics from the Urban Redevelopment Authority, prices of private residential properties decreased by 0.1% in 2Q17, compared with the 0.4% decline in the previous quarter.

For landed properties, prices declined by 0.3%, a slight improvement with the 1.8% decrease in the previous quarter. Prices of non-landed properties declined by 0.1%, after remaining unchanged in the previous quarter.

The prices of non-landed properties in Core Central Region (CCR) decreased by 0.5%, compared with the 0.4% decrease in the previous quarter.

Meanwhile, the prices of non-landed properties in Rest of Central Region (RCR) increased by 0.6%, compared with the 0.3% increase in the previous quarter. Prices of non-landed properties in Outside Central Region decreased by 0.3%, compared with an increase of 0.1% in the previous quarter.
 

Join Singapore Business Review community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Top News

DBS and OCBC expected to deliver steady Q1 net profits
Their net interest margins will ease as a result of their Hong Kong loans.
Singapore's maritime cluster navigates towards digital, green future
Adapting to emerging challenges, such as the adoption of alternative fuels, is deemed crucial for the country's maritime sector.
Shipping & Marine
SCG and A*STAR unveil joint labs for cellular immunotherapy enhancement
The partnership has a funding of nearly $30m supported under Singapore's Research, Innovation and Enterprise 2025 plan.
Healthcare